Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan.
Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan.
Ann Oncol. 2012 Aug;23(8):2173-2178. doi: 10.1093/annonc/mdr581. Epub 2012 Jan 9.
We analyzed the relationship between cholelithiasis and cancer risk in a network of case-control studies conducted in Italy and Switzerland in 1982-2009.
The analyses included 1997 oropharyngeal, 917 esophageal, 999 gastric, 23 small intestinal, 3726 colorectal, 684 liver, 688 pancreatic, 1240 laryngeal, 6447 breast, 1458 endometrial, 2002 ovarian, 1582 prostate, 1125 renal cell, 741 bladder cancers, and 21 284 controls. The odds ratios (ORs) were estimated by multiple logistic regression models.
The ORs for subjects with history of cholelithiasis compared with those without were significantly elevated for small intestinal (OR=3.96), prostate (OR=1.36), and kidney cancers (OR=1.57). These positive associations were observed ≥10 years after diagnosis of cholelithiasis and were consistent across strata of age, sex, and body mass index. No relation was found with the other selected cancers. A meta-analysis including this and three other studies on the relation of cholelithiasis with small intestinal cancer gave a pooled relative risk of 2.35 [95% confidence interval (CI) 1.82-3.03].
In subjects with cholelithiasis, we showed an appreciably increased risk of small intestinal cancer and suggested a moderate increased risk of prostate and kidney cancers. We found no material association with the other cancers considered.
我们分析了 1982 年至 2009 年在意大利和瑞士进行的病例对照研究网络中胆石病与癌症风险之间的关系。
该分析包括 1997 例口咽癌、917 例食管癌、999 例胃癌、23 例小肠癌、3726 例结直肠癌、684 例肝癌、688 例胰腺癌、1240 例喉癌、6447 例乳腺癌、1458 例子宫内膜癌、2002 例卵巢癌、1582 例前列腺癌、1125 例肾细胞癌、741 例膀胱癌和 21284 例对照。通过多因素逻辑回归模型估计比值比(ORs)。
与无胆石病史者相比,有胆石病史者的小肠癌(OR=3.96)、前列腺癌(OR=1.36)和肾癌(OR=1.57)的 OR 显著升高。这些阳性关联在胆石病诊断后≥10 年观察到,且在年龄、性别和体重指数的各个亚组中一致。与其他选定的癌症无关联。纳入这项研究以及另外三项关于胆石病与小肠癌关系的研究的荟萃分析显示,胆石病相关的小肠癌相对风险为 2.35[95%置信区间(CI)1.82-3.03]。
在胆石病患者中,我们发现小肠癌的风险明显增加,提示前列腺癌和肾癌的风险适度增加。我们未发现与其他考虑的癌症有实质性关联。